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 ABSTRACT 
 Suppression of cyclic activity in cattle is often desired 
in alpine farming and for feedlot cattle not intended 
for breeding. A cattle-specific anti-GnRH vaccination 
(Bopriva, Zoetis Australia Ltd., West Ryde, Australia) 
is approved for use in heifers and bulls in New Zealand, 
Australia, Mexico, Brazil, Argentina, Turkey, and Peru. 
Eleven healthy, cyclic Swiss Fleckvieh cows were in-
cluded in the study and vaccinated twice with Bopriva 
4 wk apart. Injection site, rectal body temperature, and 
heart and respiratory rates were recorded before and 3 
d following each vaccination. Blood samples were taken 
weekly for progesterone and estrogen analysis and to 
determine GnRH antibody titer. Ovaries were exam-
ined weekly, using ultrasound to count the number of 
follicles and identify the presence of a corpus luteum. 
Thirty weeks after the first vaccination, the cows were 
subjected to a controlled internal drug-releasing device-
based Select-Synch treatment. The GnRH antibody ti-
ters increased after the second vaccination and peaked 
2 wk later. Estrogen levels were not influenced by vacci-
nation, and progesterone level decreased in 7 of 11 cows 
up to 3 wk after the second vaccination and remained 
low for 10 to 15 wk following the second vaccination. 
The number of class I follicles (diameter ≤5 mm) was 
not influenced by vaccination, whereas the number of 
class II follicles (diameter 6–9 mm) decreased between 
7 and 16 wk after the first vaccination. Class III fol-
licles (diameter >9 mm) were totally absent during this 
period in most cows. The median period until recur-
rence of class III follicles was 78 d from the day of the 
second vaccination (95% confidence interval: 60–92 d). 
After vaccination, all cows showed swelling and pain at 
the injection site, and these reactions subsided within 2 
wk. Body temperature and heart and respiratory rates 
increased after the first and second vaccinations and re-
turned to normal values within 2 d of each vaccination. 
The cows in our study were not observed to display 
estrus behavior until 30 wk after the first vaccination. 
Therefore, a Select-Synch protocol was initiated at 
that time. Ten cows became pregnant after the first in-
semination (the remaining cow was reinseminated once 
until confirmed pregnancy). Bopriva induced a reliable 
and reversible suppression of reproductive cyclicity for 
more than 2 mo. The best practical predictor for the 
length of the anestrus period was the absence of class 
III follicles. 
 Key words:   anti-gonadotropin releasing hormone 
(anti-GnRH) ,  gonadotropin releasing hormone (GnRH) , 
 immunization ,  antibody titer ,  anestrus 
 INTRODUCTION 
 Estrus inhibition is frequently requested by livestock 
owners. Preventing recurrent estrus is desired for alpine 
farming and for feedlot cattle not intended for breed-
ing. These cows, when untreated, cause disturbance 
in the herd during estrus and, additionally, are often 
pregnant at slaughter. In contrast to surgical methods 
(ovariectomy; Hobson and Hansel, 1972; Bleul et al., 
2005), mechanical contraception methods (foreign ob-
jects in the uterus; Turin et al., 1997), or permanent 
administration of progesterone derivatives (Burns et 
al., 1993; Jacobsen et al., 1995; Denicola et al., 1997; 
Petta et al., 1998), immunological techniques represent 
an animal-friendly method for controlling populations 
(Miller et al., 2000; Curtis et al., 2002). Immunization 
against GnRH has been used to suppress sexual be-
havior and to prevent the development of secondary 
sexual characteristics in males (Finnerty et al., 1998; 
Cook et al., 2000; Thompson, 2000; D’Occhio et al., 
2001; Aïssat et al., 2002; Janett et al., 2003, 2009b, 
2012a; Turkstra et al., 2005; Theubet et al., 2010) as 
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well as in females (Dalin et al., 2002; Imboden et al., 
2006; Elhay et al., 2007; Janett et al., 2009a). In heif-
ers, administration of a human chorionic gonadotropin 
or LH vaccine (Johnson et al., 1988), as well as a GnRH 
vaccine (Johnson et al., 1988; Adams and Adams, 1990; 
Prendiville et al., 1995; Bell et al., 1997; Stevens et 
al., 2005), has been tested. It could be demonstrated 
that antibody titers, ovarian function, progesterone 
concentration, and uterus weight differed significantly 
after immunization with a recombinant GnRH antigen 
from nonimmunized heifers (Geary et al., 2006). Note 
that these studies all used different presentations of the 
GnRH antigen as well as different adjuvants. Immu-
nization with GnRH prevented the growth of follicles 
>5 mm in diameter and induced anestrus. However, 
as in mature mares (Dalin et al., 2002; Imboden et al., 
2006), the effect of the vaccine varied individually in 
terms of duration and behavior (Prendiville et al., 1995; 
Crowe et al., 2001). No information is available in the 
literature regarding reversibility to estrus in cows after 
vaccination against GnRH.
The aim of the present study was to evaluate the 
effect of an active immunization against GnRH (Bo-
priva, Zoetis Australia Limited, West Ryde, Austra-
lia) on GnRH antibody titer, plasma progesterone 
and estrogen concentrations, and ovarian activity. Of 
particular interest were the duration and reversibility 
of the vaccination-induced anestrus. We hypothesized 
that the vaccine would increase GnRH antibody titer, 
decrease the plasma concentrations of progesterone and 
estrogen, and reduce the number of follicles >5 mm in 
diameter and therefore induce a phase of anestrus of 
unknown length. Once pregnancy was confirmed, cows 
were terminated from the study.
MATERIALS AND METHODS
Animals and Inclusion and Exclusion Criteria
Eleven lactating Swiss Fleckvieh cows (cows A 
through M), from second to sixth lactation (median 
= third lactation) and 88 to 201 d postpartum (me-
dian = 137 d) were included in the study. Inclusion 
criteria were regular cyclicity before first treatment and 
uterine health. A uterine swab was taken in diestrus 
for microbiological and cytological analysis. Results of 
microbiological samples had to be negative on bacterial 
culture, and less than 5% neutrophils (as a proportion 
of total cells) had to be counted to demonstrate uterine 
health, according to Gilbert et al. (2005). Exclusion cri-
teria were a history of preceding dystocia or caesarian 
section, acute or chronic endometritis, cystic ovarian 
disease, or general diseases (e.g., chronic mastitis, claw 
diseases).
Animal Care and Housing
The cows were housed in tie-stalls on straw bedding. 
From May to October, the cows had daily access to 
pasture. During winter months, they had access to a 
courtyard 3 times a week. They were fed an individu-
ally calculated ratio of hay and concentrate determined 
on the basis of individual milk yield, had free access to 
water, and were milked twice daily.
Treatment with GnRH Vaccine
The treatment consisted of 2 vaccinations (initial and 
booster) with the anti-GnRH vaccine Bopriva (Zoetis 
Australia Ltd.) 4 wk apart (d 0 and 30). Bopriva con-
tains an analog of GnRH linked to a carrier protein 
combined with a synthetic aqueous adjuvant (400 μg of 
GnRH-protein-conjugate per mL) and is registered with 
claims to suppress testosterone blood levels in postpu-
bertal bulls and estrus behavior in postpubertal heifers. 
The dosage used for both the initial and the booster 
vaccination was 400 μg of GnRH-protein-conjugate (1 
mL of Bopriva). All injections were administered sub-
cutaneously on the right side of the neck.
All animal experimentation was performed with 
permission and in accordance with Swiss law (Nr. BE 
29/11).
Clinical Evaluation and Side Effects
Clinical evaluation included the parameters of body 
temperature, heart and respiratory rates, and daily 
milk production. The injection site was meticulously 
inspected for signs of tissue reaction. Cows were exam-
ined directly before each vaccination (d 0) and daily 
on the following 3 d or until all parameters examined 
had returned to normal. Estrus behavior observation 
was conducted daily after feeding on pasture or in the 
courtyard.
Blood Sampling, GnRH Antibody Titer,  
and Hormones
In all animals, blood was sampled weekly starting 3 
wk before vaccination until pregnancy was confirmed. 
The blood samples were collected by venipuncture from 
the coccygeal vein into heparinized tubes and centri-
fuged (4,000 × g, 10 min), and plasma was then stored 
at −18°C for later analysis.
GnRH Antibody Titers. Antibody titers of GnRH 
were determined by dissociation-enhanced lanthanide 
fluorescence immunoassay (DELFIA; PerkinElmer 
Pty Ltd., Glen Waverly, Australia) and results were ex-
pressed as relative light units (RLU). Briefly, 384-well, 
streptavidin-coated plates (PerkinElmer Pty Ltd.) were 
coated for 1 h at room temperature with 1 μg/mL of 
biotinylated modified GnRH peptide in DELFIA buf-
fer (50 mM Tris-HCl, 0.9% NaCl, 0.05% Tween 20, 20 
μM EDTA, 0.2% ovalbumin). Plates were washed and 
then incubated for 1 h at room temperature with 50-μL 
aliquots of cattle samples serially diluted to 1:800 in 
DELFIA buffer. Unbound plasma and antibodies were 
removed by washing, and bound antibody was detected 
by incubating plates for a further 1 h with 50 μL of 
europium-labeled protein G (PerkinElmer Pty Ltd.). 
After washing off excess europium-labeled protein G, 
DELFIA Enhancement Solution (PerkinElmer Pty 
Ltd.) was added to all wells to dissociate bound lan-
thanide from the antigen, forming a highly fluorescent 
chelate. After 10 min, the intensity of fluorescence was 
measured by excitation at 340 nm and emission read-
ings at 615 nm using a time-resolved fluorometer (Envi-
sion 2102 Multireader, PerkinElmer Pty Ltd.). Pooled 
nonvaccinated cattle samples served as a negative 
control. Unknown samples were compared with serial 
dilutions of a standard positive reference immune cattle 
sample. Calculation of a standard curve and reading of 
unknown samples were performed using the WorkOut 
2.5 software (Dazdaq Solutions Ltd., East Sussex, UK). 
Intra- and interassay coefficients of variation (CV) 
were 6.7 and 8.5%, respectively. Serology titers showed 
a 120-fold range from 3,850 RLU for negative samples 
to 495,000 titers units for immune samples, with 11,500 
RLU being taken as the lower cut-off differentiating 
positive from negative samples. The lowest detection 
level of GnRH antibody titer was 3,850 RLU.
Hormone Analysis. Progesterone concentration 
was measured using RIA (Immunotech, Beckman Coul-
ter, Sinsheim, Germany). The intraassay CV was 5.3% 
and the interassay CV was 7.7%, determined by using a 
bovine serum pool measured 30 times within a test rou-
tine and within 25 assay runs. The analytical sensitivity 
was 0.05 ng/mL and the measurement range was 0.05 
to 50 ng/mL. The assay was performed according to 
the manufacturer’s instructions. Total estrogen concen-
tration was measured after cleavage of glucoronidated 
and sulfated estrogen by using 0.2% β-glucoronidase-
acrylsulfatase (Merck, Darmstadt, Germany) for 2 
h at 37°C in sodium actetate buffer (Sigma Aldrich, 
pH 4.8). Then, steroid hormones were extracted from 
plasma (300 μL) by adding 3 mL of ether (30% bu-
tylmethylether, 70% benzene). Then, a direct enzyme-
immunoassay on microtiter plates using a secondary 
antibody-coating technique and horseradish peroxidase 
as the enzyme label were used to measure total estro-
gen concentration. The enzyme-immunoassay was pre-
viously described by Meyer et al. (1990) and Prakash 
et al. (1987). The used antiserum was raised against 
17-estradiol hemisuccinate, and 17-estradiol hemisuc-
cinate horseradish peroxidase was used as steroid-en-
zyme conjugate (purchased from Technical University 
of Munich, Freising-Weihenstephan, Germany). The 
intra- and interassay CV were calculated by repeated 
measurements of bovine plasma samples. The minimal 
detectable concentration was 8 pg/mL. The recovery 
was 84.6 to 96.2%, the intraassay CV was 8.5% and the 
interassay CV was 17.4%.
Gynecological Examination,  
Insemination, and Pregnancy
The cows were examined weekly by rectal palpation 
until they were inseminated. Using ultrasonography 
(Aquila Pro Vet, Esaote Piemedical, Köln, Germany), 
the number of follicles was recorded and assigned to 1 of 
3 categories, according to the classification of Moreira 
et al. (2000): class I follicles (≤5 mm in diameter), 
class II follicles (6–9 mm in diameter), and class III 
follicles (>9 mm and <2 cm in diameter) (Vanholder 
et al., 2006). The presence of a corpus luteum (CL) 
was also noted. Thirty weeks after the first vaccination, 
all cows were treated with a Select-Synch protocol and 
inseminated. The Select-Synch protocol started with 
an injection of 20 μg of buserelin i.m. (Receptal, MSD 
Animal Health GmbH, Lucerne, Switzerland) and an 
intravaginal progesterone-releasing device containing 
1.9 g of progesterone (Eazi-Breed CIDR B, Zoetis, 
Zurich, Switzerland). Six days later, the cows were 
injected with 500 μg of cloprostenol i.m. (Estrumate, 
MSD Animal Health GmbH), and the CIDR was re-
moved the next day. Cows were inseminated 48 and 72 
h after CIDR removal and received 20 μg of buserelin 
i.m. with the first insemination. Pregnancy diagnosis 
was performed 35 d after the first insemination. Cows 
not pregnant were further treated individually. Cows 
with confirmed pregnancies were slaughtered.
Statistical Analysis
Metric variables were described with means, medi-
ans, standard deviations, and ranges. Categorical data 
were analyzed by using contingency tables. We applied 
nonparametric methods, as the rank correlation coef-
ficient for the relationship of variables that were at 
least ordinal, and nonparametric confidence intervals. 
The cow was the statistical independent unit; we ob-
served dependent data within each cow. Because the 
number of cows was small, we could not apply simple 
statistical methods, and more sophisticated methods 
were not appropriate. Hence, P-values (e.g., of the rank 
correlation or χ2 test of the contingency tables) should 
be interpreted only as an explorative indication. Only 
when the cow was used as statistical unit were the P-
values of test and nonparametric confidence intervals 
appropriate and exact. We used SAS software (SAS 
Institute Inc., Cary, NC) and Statxact software (Cytel 
Inc., Cambridge, MA) for the statistical analyses.
RESULTS
GnRH Antibody Titers
Antibody titers began to increase 2 to 3 wk after 
the first vaccination but increased significantly after 
the second vaccination and reached peak values at ap-
proximately 6 wk after the first vaccination (Figure 1). 
Titers decreased to basal values approximately 12 to 
17 wk after the first vaccination in all cows. In 7 of 11 
cows, the titers remained at basal levels for the rest of 
the study. In 4 cows, titers increased slightly from basal 
values at wk 18 and 22 (cows G and H, respectively) 
and at wk 24 and 25 (cows A and F, respectively). 
The GnRH antibody levels were below the detection 
limit at the time of insemination in all cows. A large 
variation in the maximum titer was seen in individual 
vaccinated cows, ranging between 21,174 units (cow 
G) and 207,830 units (cow B). A titer exceeding 3,850
units (detection limit) was found from 17 d (95% CI: 
16.5–17) to 97.5 d (95% CI: 83–111.5) after the first 
vaccination.
Plasma Progesterone and Estrogen Concentration
The maximal plasma progesterone concentration 
measured during the entire study was 49 ng/mL and 
the minimal value was 0.1 ng/mL (Figure 2). The 
maximal plasma total estrogen concentration measured 
during the study was 102.0 pg/mL and the minimal 
value was the detection limit of 8 pg/mL.
At the time of the first vaccination, 6 cows (A, B, 
F, G, L, M) showed plasma progesterone concentra-
tions >3 ng/mL, 4 cows (H, I, J, K) had values <1 
ng/mL, and cow C had a concentration of 1.8 ng/
mL. The individual plasma progesterone level fluctu-
ated greatly in the first weeks after vaccination. In 
7 cows (A, B, C, G, H, K, M), plasma progesterone 
decreased to a basal level 3 to 7 wk after the first 
vaccination (i.e., up to 3 wk after the booster) until 
wk 14 to 19. After this time, an increase in plasma 
progesterone concentration was apparent in 6 cows 
(A, C, G, H, K, M). One cow (F) showed an increase 
in plasma progesterone concentration from wk 5 that 
remained high until wk 16. Cows I and J showed a 
plasma progesterone concentration >5 ng/mL in wk 
Figure 1. Gonadotropin-releasing hormone antibody titers of 11 cows (A through M) after 2 vaccinations (d 0 and d 30, arrow) with anti-
GnRH vaccine (Bopriva, Zoetis Australia Ltd., West Ryde, Australia). Peak values are shown 6 wk after the first vaccination. DELFIA = 
dissociation-enhanced lanthanide fluorescence immunoassay.
5, which increased above 10 and 15 ng/mL until wk 28 
and 17, respectively. The plasma progesterone level of 
cow I returned to a fluctuating pattern after wk 28. In 
cow J, progesterone levels between 15 and 25 ng/mL 
were measured during wk 17 and 28. Cow L showed a 
continuous increase of the plasma progesterone level 
from wk 5 to 12 and reached a peak value of 28.9 ng/
mL. The level of plasma progesterone concentration 
was positively correlated with the presence of a CL 
(Spearman r = 0.75; P < 0.0001).
Seven cows (A, B, C, F, H, I, J) showed fluctuating 
values of total plasma estrogen concentration during 
the study (data not shown), with peak values of 33.1 
to 58.3 pg/mL, and minimal values below the detection 
limit. Cows K, L, and M showed fluctuating values un-
til wk 11 after the first vaccination and then the values 
decreased below the detection limit until insemination, 
except for a very slight increase for cows L and M in 
wk 15 and 19, respectively. Cow G showed fluctuating 
values of total plasma estrogen concentration through-
out the study, with very high peak values (102.0 pg/
mL at wk 13).
Ovarian Ultrasonography
The number of class I follicles did not vary for 30 wk 
after the first immunization (Figure 3), whereas the 
number of class II follicles decreased between wk 7 and 
17, although they were still present in some cows. Class 
III follicles were completely absent from wk 7 (±2 wk) 
to wk 16 (±3 wk) after the first vaccination (i.e., 3 
wk after the booster) in all the cows except for cow G 
(Figure 4 a,b).
At the time of the first vaccination, a CL was present 
in 70% (8/11) of the cows. Four of the 11 cows devel-
oped a persistent CL over a maximum of 166 d after the 
second vaccination.
Figure 5 illustrates the correlation between GnRH 
antibody titers (d 17–97.5) and number of class III fol-
licles; fewer class III follicles were present when GnRH 
antibody titers were high (P < 0.0001; phi coefficient 
= −0.461).
Pregnancy Diagnosis
Ten of 11 cows were confirmed pregnant 35 d after 
insemination following the Select-Synch protocol; 1 cow 
(J) was not pregnant at this time. In cow J, a CL on the 
right ovary and some class II follicles on both ovaries 
were observed, and the uterus showed no pathological 
findings. The cow was injected with 500 μg of clopro-
stenol i.m. (Estrumate, MSD Animal Health GmbH) 
on d 39 postinsemination and with 20 μg of buserelin 
i.m. (Receptal, MSD Animal Health GmbH) on d 41. 
Inseminations were performed on d 41 and 42 and she 
was confirmed pregnant 35 d later.
Figure 2. Plasma progesterone values of 11 cows (A through M) after 2 vaccinations (d 0 and d 30, arrow) with anti-GnRH vaccine (Bopriva, 
Zoetis Australia Ltd., West Ryde, Australia). 
Clinical Evaluation and Adverse Effects
No estrus behavior was observed in the GnRH-vacci-
nated cows even after anti-GnRH titers reached basal 
values and although class III follicles and the presence 
of a CL on the ovaries indicated resumption of repro-
ductive cyclicity.
All cows treated with Bopriva showed a swelling at 
the injection site (varying in severity) and moderate to 
substantial local pain. In all animals, the local reactions 
subsided within 2 to 4 wk. A transient increase in rectal 
body temperature was apparent 24 h after the first (me-
dian; 25% and 75% quartiles: 39.2°C; 39.1°C, 40.3°C) and 
the second vaccination (39.5°C; 38.8°C, 40.4°C; Table 
1). Heart rate (beats per min) increased after the first 
(88; 84, 100) and the second (88; 80, 90) vaccinations 
and returned to normal within 48 h after vaccination. 
Respiratory rate (breaths/min) increased after the first 
(34; 36, 56) and the second (32; 40, 48) vaccinations 
and returned to normal within 48 h postvaccination. No 
signs of apathy, reduced food intake, or decrease in milk 
production were observed. In 1 cow (J), a hydrometra 
was diagnosed 28 wk after the first vaccination and was 
successfully treated with 500 μg of cloprostenol i.m. (Es-
trumate, MSD Animal Health GmbH).
DISCUSSION
All cows showed similar patterns of GnRH antibody 
production after immunization, with a rapid onset of 
immune response and a peak 2 to 3 wk after the second 
vaccination. However, the maximal values of individual 
anti-GnRH antibodies varied greatly, due to the mul-
tistep involvements required for the immune system to 
establish antibodies to exposed antigens, as well as the 
individual variation in terms of the condition of the 
animals, their nutritional state, and a strong genetic 
component for major histocompatibility complex (Fluri 
et al., 2006).
Antibody titers >3,850 (detection limit) were found 
between 17 and 97.5 d after the first vaccination. This 
duration of effect is consistent with results in pubertal 
bull calves (Theubet et al., 2010; Janett et al., 2012a) 
but shorter than that observed in prepubertal bull 
calves (Janett et al., 2012b). The longer duration seen 
in prepubertal bull calves is most likely due to the vac-
cine resulting in a delay in the onset of puberty.
As expected, the number of class I follicles was not 
influenced by vaccination. Class I follicles in cattle are 
independent of gonadotropin (Campbell et al., 1995). 
The number of class II follicles was partly reduced, but 
class II follicles did not completely disappear after the 
second vaccination. In heifers, follicles with a diameter 
>5 mm are suppressed after vaccination against GnRH 
(Prendiville et al., 1995; Crowe et al., 2001). In our 
study, class III follicles were completely absent in 10 of 
11 cows between 7 and 16 wk following 2 vaccinations 
of Bopriva. Cow G exhibited a low immune response 
to Bopriva as reflected in low GnRH antibody titers 
Figure 3. Number of class I follicles of 11 cows (A through M) after 2 vaccinations (d 0 and d 30, arrow) with anti-GnRH vaccine (Bopriva, 
Zoetis Australia Ltd., West Ryde, Australia). 
Figure 4. (a) Number of class III follicles of 11 cows (A through M) after 2 vaccinations (d 0 and d 30, arrow) with anti-GnRH vaccine 
(Bopriva, Zoetis Australia Ltd., West Ryde, Australia). These follicles were completely absent from wk 7 (±2 wk) to wk 16 (±3 wk) for all the 
cows except for cow G. (b) Survival analysis of class III follicles (empirical distribution, function of length in days of absence of class III follicles 
until class III follicles are present again). Color version available in the online PDF.
Figure 5. Association of class III follicles with GnRH antibody titer. DELFIA = dissociation-enhanced lanthanide fluorescence immunoassay.
Table 1. Temperature, heart rate, and respiration before vaccination (d 0) and on the 3 d following the first 
vaccination (1) with anti-GnRH vaccine (Bopriva, Zoetis Australia Ltd., West Ryde, Australia) and the second 
vaccination (2) 
Trait 25% quartile Median 75% quartile
Temperature (°C)
 d 0 (1) 38.1 38.4 38.4
 d 1 (1) 39.1 39.2 40.3
 d 2 (1) 38.2 38.4 38.6
 d 3 (1) 38.1 38.5 38.7
 d 0 (2) 38.5 38.6 38.8
 d 1 (2) 38.8 39.5 40.4
 d 2 (2) 38.1 38.7 38.8
 d 3 (2) 38.1 38.3 38.5
Heart rate (beats/min)
 d 0 (1) 68 80 84
 d 1 (1) 84 88 100
 d 2 (1) 73 80 85
 d 3 (1) 68 80 88
 d 0 (2) 72 84 90
 d 1 (2) 80 88 90
 d 2 (2) 80 84 90
 d 3 (2) 74 80 84
Respiratory rate (breaths/min)
 d 0 (1) 30 32 36
 d 1 (1) 36 44 56
 d 2 (1) 32 38 46
 d 3 (1) 36 40 46
 d 0 (2) 24 36 44
 d 1 (2) 32 40 48
 d 2 (2) 30 32 52
 d 3 (2) 28 35 42
and, subsequently, large follicle development was not 
suppressed. Earlier studies in cattle suggest that re-
cruitment of follicles is likely to be FSH-dependent and 
that selection and growth of follicles above 7 to 9 mm 
in diameter is LH-dependent (Gong et al., 1996; Bao et 
al., 1997).
Plasma progesterone (e.g., estrus values vs. diestrus 
values) at the time of the first vaccination did not af-
fect later values of plasma progesterone concentration 
during the study. Despite the production of GnRH 
antibodies, 4 cows showed a CL and a plasma proges-
terone concentration >1 ng/mL. Earlier studies in heif-
ers and ewes (Hixon et al., 1975; Hughes et al., 1987) 
suggested that estradiol production from follicles could 
play a role in luteolysis; therefore, the suppression of 
follicle development could prolong the lifespan of a CL 
(Okuda et al., 2002). The lack of class III follicles might 
explain why no luteolysis occurred in some cows. In 
our study, the total plasma estrogen concentration was 
not affected by the production of GnRH antibodies. 
A good correlation exists between total estrogen and 
estradiol-17β (Mondal et al., 2006). Other studies in 
mares (Dalin et al., 2002; Imboden et al., 2006) and 
heifers (Prendiville et al., 1995) described a reduced 
estradiol-17β level after GnRH vaccination. Dalin et 
al. (2002) indicated that in mares, the estrus cycle 
stage at first immunization might have an influence on 
hormonal levels. Furthermore, in the study of Dalin et 
al. (2002), ovarian atrophy in mares did not correlate 
with cycle blockade. Among all parameters evaluated 
in our study, the suppression of class III follicles was 
the most reliable and easily detectable parameter for 
clinicians to predict the efficiency of the vaccine. Large 
follicles are almost always present in healthy cyclic cows 
because follicle growth occurs in waves (Lucy et al., 
1992). In this study, the class III follicles were absent 
from wk 7 to 16 after the primary vaccination and cows 
entered anestrus approximately 3 wk after the booster 
injection. An important finding of the current study 
was that the immunization against GnRH was entirely 
reversible as shown by the return to basal levels of the 
GnRH antibody titer and with successful insemination 
of all the cows. These results confirm that Bopriva can 
be used in a safe manner in cows, as already seen in bull 
calves (Theubet et al., 2010; Janett et al., 2012a,b). In 
our study, the general condition and milk yield of cows 
were not disturbed by the vaccine, despite a short-term 
increase in rectal body temperature and a local reaction 
at the site of vaccination (data not shown). One note-
worthy adverse effect was the hydrometra developed 
by cow J. This was the only cow needing 2 insemina-
tions to become pregnant. The authors did not find any 
other case of hydrometra published in conjunction with 
the use of GnRH immunization. It is unclear whether it 
occurred causally or as a coincidence.
In addition to seasonal breeding systems, temporary 
immunization against GnRH could be used in seasonal 
alpine pasturing systems. Cows not pregnant during the 
seasonal alpine pasturing disturb the herd because of 
recurring estrus behavior. This is especially accentuated 
in the Swiss Hérens breed, which is raised for fighting 
and selected for dominance abilities (Plusquellec and 
Bouissou, 2001). Suppression of estrus during alpine 
pasturing is highly valued but, with the exception of 
intravaginal progesterone devices, currently no phar-
maceuticals are permitted in Switzerland for produc-
tion animals. Immunization against GnRH could be 
considered an animal-friendly solution for these cows 
and producers.
The cows in our study were not observed to be dis-
playing estrus behavior until wk 30, when the Select-
Synch protocol was started. In future studies, we plan 
to evaluate estrus behavior and return to cyclicity of 
cows in herds that include a bull. Alternatively to using 
a bull, heat detection patches could be used. Further-
more, a large clinical field study is planned, in which 
we will evaluate the influence of cycle stage at first and 
second vaccinations on characteristics of hormones and 
behavior.
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